openPR Logo
Press release

Graft Versus Host Disease (GvHD) Market - Global Industry Insights, Trends and Opportunity Analysis, 2016-2024

04-03-2017 05:32 PM CET | Health & Medicine

Press release from: Biotechnology Report By CMI

Graft Versus Host Disease (GvHD) Market - Global Industry

During any transplant of stem cell and bone marrow some complications arises that may be mild or severe, those are the graft versus host disease (Gvhd) they occur especially in immune-compromised patients. During cancer treatment, the radioactive agents or the chemicals affects the healthy cells along with the cancer cells. Reconstruction of body cells affected during cancer treatment can be fixed using stem cell and bone marrow transplant. Following a high dose of chemotherapy, the bone marrow is received by patient the donor through infusion, which helps with resumption of blood cells production. Graft versus host disease occurs when particular type of white blood cells are not compatible with the existing cell type and thus, leads to an attack by the transplanted cells on the recipient body. It is a difficult procedure to diagnose the agents and the compatibility during the transplant. Symptoms of Gvhd are usually not too severe, though in some cases it can be fatal. During autologous transplant, the patient is free from such complications. Also, prior to the transplant, cells of the donor and recipient are closely screened and matched so as to avoid Gvhd by ensuring the closest possible match.

Request a sample copy of this report @ https://www.coherentmarketinsights.com/insight/request-sample/184

Graft Versus Host Disease Market Taxonomy:

By Disease Type

• Acute graft vs. host disease (aGvHD)
• Chronic graft vs. host disease (cGvHD)

By Product Type

• Monoclonal antibodies
• mTOR inhibitors
• Tyrosine kinase inhibitors
• Thalidomide
• Etanercept

High investment in research and development is expected to favor growth of the graft versus host disease market:

In the recent past, the graft versus host disease market has significantly evolved with the introduction of biological and patented small molecule immunosuppressive therapies and been added to the treatment regime. The current research and development programs in Gvhd are equipped with novel therapies such as Adienne Pharma’s Begedina and mesenchymal stem cell therapies. R&D strategies in Gvhd are characterized by an increasing trend towards maintaining appropriate prophylactic regimens and inhibiting proliferation and activation of T-cell. Such regimens in Gvhd are tailored to conditioning and transplant type and used for hematopoietic stem cell transplantation (HSCT). However, there is significant possibility of risk of opportunistic infection during this process.

Request for Complete TOC before buying this exclusive Report by CMI @ https://www.coherentmarketinsights.com/ongoing-insight/toc/184

However, most of the ventures in research and development process, including academically running clinical studies regarding targeting niche subgroup under Gvhd such as steroid refractory aGVHD and cGVHD, are key R&D strategies in the GVHD pipeline, with around 30 products in the pipeline targeting such populations. Extensive research and development activities are expected to favor growth of the graft versus host disease industry in the near future.

Large unmet needs in the Gvhd management are one of the most important factors fueling growth of the graft versus host disease market. At present there are very few or no guidelines for management of graft versus host disease that can precisely maintain the data for the large population suffering from Gvhd, though certain recommendations for such therapies are in place.

Get Discount for First Time Buyers @ https://www.coherentmarketinsights.com/insight/request-discount/184

Lack of regulatory guidelines pegs back growth of graft versus host disease market

The disease is orphan in nature, which can be one of the important factors affecting the lack of guidelines and treatment regimes. Lack of randomized clinical trials is another factor that contributes towards non-popularity of Gvhd due to the use of variable clinical trial endpoints conducted studies till date. This has resulted in inappropriate clinical evidences, which are not comparable and not directly applicable to all Gvhd patient groups. However, advancements in the process of early detection of symptoms is projected to support growth of the graft versus host disease market in the near future.

Major research universities in the GvHD market are engaged in research and development processes to further enhance the outcomes of the therapy. For instance, research conducted by the University Of Michigan, in 2017, revised the understanding regarding the graft vs. host disease origins, which can offer new direction for potential therapy in the near future.

Browse Research Report @ https://www.coherentmarketinsights.com/ongoing-insight/graft-versus-host-disease-market-184

Market players in the GvHD market focusing on inorganic growth strategies to strength product portfolio

The global graft versus host disease market is competitive and fragmented. Major players in the market are developing novel products and spending significantly in research and development, along with major acquisitions and collaborations to achieve competitive edge over their counterparts. For instance, Kalytera Therapeutics, Inc. acquired Talent Biotechs Ltd. – an Israeli-based developer of proprietary cannabidiol therapeutic. This is expected to favor the increase in company’s product portfolio. Some of the key players in the Gvhd market are Sanofi, Novartis AG, Neovii Biotech GmbH, Merck & Co., Astellas Pharma Inc., Soligenix, Inc., and Mesoblast Ltd.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Visit Coherent Market Insights Blog @ https://blog.coherentmarketinsights.com/
Connect with us on LinkedIn @ https://www.linkedin.com/company/coherent-market-insights

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Graft Versus Host Disease (GvHD) Market - Global Industry Insights, Trends and Opportunity Analysis, 2016-2024 here

News-ID: 489722 • Views:

More Releases from Biotechnology Report By CMI

Industrial Microbiology Market to Surpass US$ 16,112.0 Million Threshold by 2025 Globally with North America Positioned as the Growth Engine
Industrial Microbiology Market to Surpass US$ 16,112.0 Million Threshold by 2025 …
Industrial Microbiology–Solving Big Issues with Micro Size/Microbial Revolution Industrial Microbiology involves commercial use of micro-organisms in various industrial processes such as fermentation. Use of micro-organisms for production processes has been in use since 18th century and was facilitated by discovery of various microorganisms over the years. Depending on nature of process, the industrial microbiology has two aspects, namely production of microbial products through fermentation processes and use of microorganisms for services,
Natural Killer Cells Market - Global Industry Insights, Trends and Opportunity Analysis, 2016–2024
Natural Killer Cells Market - Global Industry Insights, Trends and Opportunity A …
Natural killer cells are a form of granular lymphocytes of varying sizes that play an important role in innate immunity in the human body. They typically constitute of around 10% of total blood lymphocytes as compared to around 70% and 20% of T cells and B cells, respectively. Natural killer cells are cytotoxic in nature and are able to kill their targets cells by two different mechanisms: as antibody dependent
Psoriasis Treatment Market - Global Industry Insights, Trends and Opportunity Analysis, 2016–2024
Psoriasis Treatment Market - Global Industry Insights, Trends and Opportunity An …
Psoriasis Treatment Market Overview Psoriasis is a non-communicable autoimmune disease characterized by patches of abnormal skin. These skin spots are red, itchy, and scaly which may be small and localized or cover the entire body. Skin injury may cause psoriatic skin changes at that spot, a phenomenon called Koebner phenomenon. There are five main types of psoriasis namely Plaque, Guttate, Inverse, Pustular, and Erythrodermic. Plaque psoriasis, also known as psoriasis vulgaris, is
Psoriasis Treatment Market - Global Industry Insights, Trends and Opportunity Analysis, 2016–2024
Psoriasis Treatment Market - Global Industry Insights, Trends and Opportunity An …
Psoriasis Treatment Market Overview Psoriasis is a non-communicable autoimmune disease characterized by patches of abnormal skin. These skin spots are red, itchy, and scaly which may be small and localized or cover the entire body. Skin injury may cause psoriatic skin changes at that spot, a phenomenon called Koebner phenomenon. There are five main types of psoriasis namely Plaque, Guttate, Inverse, Pustular, and Erythrodermic. Plaque psoriasis, also known as psoriasis vulgaris, is

All 5 Releases


More Releases for Gvhd

Graft Versus Host Disease (GVHD) - Drug Pipeline Landscape, 2022
Graft Versus Host disease (GVHD) is an immune mediated systemic disorder associated with complex interaction between donor and recipient adaptive immunity. It is a common complication after hematopoietic stem cell transplant (HCT), here the graft recognizes the host as a foreign and attack the recipient's body cell. GvHD is of two types: acute GvHD - which develops within 100 days of transplantation and chronic GvHD - which develops after 100
Graft Versus Host Disease (GvHD) Market Expected to Expand at a Steady 2022-2028 …
Coherent Market Insights have added a new research study on Title Graft Versus Host Disease (GvHD) Market, Global Outlook and Forecast 2022-2028 with detailed information & Key Players Such as Gvhd market are Sanofi, Novartis AG, Neovii Biotech GmbH, Merck & Co., Astellas Pharma Inc., Soligenix, Inc., and Mesoblast Ltd. The Study provides in-depth comprehensive analysis includes Clear Market definitions, classifications, manufacturing processes, cost structures, development policies and plans. The
Graft Versus Host Disease GvHD Treatment Market Investment Research Report 2016- …
Graft versus Host disease occurs after a stem cell or bone marrow transplant. High dose treatment destroy cancer cells along with that it simultaneously destroys healthy cells. Stem cell and bone marrow transplant treatments are used in reconstructing damaged cells, surrounding cancer tumors. Normally after high dose treatment, patient receives bone marrow from a donor through drip which resumes production of blood cells. Graft versus Host Disease occurs when certain
Graft Versus Host Disease GvHD Treatment Market Revenue and Value Chain 2016-202 …
Graft versus Host disease occurs after a stem cell or bone marrow transplant. High dose treatment destroy cancer cells along with that it simultaneously destroys healthy cells. Stem cell and bone marrow transplant treatments are used in reconstructing damaged cells, surrounding cancer tumors. Normally after high dose treatment, patient receives bone marrow from a donor through drip which resumes production of blood cells. Graft versus Host Disease occurs when certain
Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2017 to its growing collection of premium market research reports. Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2017, provides an overview of the Graft Versus Host Disease (GVHD) (Immunology) pipeline landscape. Graft-versus-host disease (GVHD) is a complication that can occur after
Graft Versus Host Disease (GvHD) Market - Global Industry Analysis 2024
During any transplant of stem cell and bone marrow some complications arises that may be mild or severe, those are the graft versus host disease (Gvhd) they occur especially in immune-compromised patients. During cancer treatment, the radioactive agents or the chemicals affects the healthy cells along with the cancer cells. Reconstruction of body cells affected during cancer treatment can be fixed using stem cell and bone marrow transplant. Following a